Kinnari Patel
Präsident bei ROCKET PHARMACEUTICALS, INC.
Vermögen: 8 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Kinnari Patel
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 70 | |
| Public Company | Biotechnology | 28 | |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kinnari Patel
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal Sales & Marketing | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member President | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Compliance Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer Private Equity Investor Private Equity Investor | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Purdue University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Doctorate Degree Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree Corporate Officer/Principal | |
Asylia Therapeutics, Inc.
 Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Bristol-Myers Squibb Foundation | Director/Board Member Director/Board Member | ||
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
| Duke University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Indian Institute of Technology Roorkee | College/University | Graduate Degree Undergraduate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| The University of California, San Francisco | College/University | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Chalmers University of Technology | College/University | Graduate Degree Director/Board Member | |
| The College of William & Mary | College/University | Undergraduate Degree Undergraduate Degree | |
RTW Investments LP
 RTW Investments LP Investment ManagersFinance RTW Investments LP (RTW) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Roderick Wong in 2010. RTW provides discretionary advisory services to various RTW Funds. | Investment Managers | Chief Executive Officer Analyst-Equity | |
| TELIGENT | Pharmaceuticals: Major | Chairman General Counsel | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| BIOGEN INC. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Davidson Kempner Capital Management LP
 Davidson Kempner Capital Management LP Investment ManagersFinance Davidson Kempner Capital Management LLC (DKCM) is an independent, SEC-registered investment advisor and hedge fund management firm headquartered in New York City. The firm was founded in 1983 by Marvin Davidson and Thomas Kempner Sr. DKCM provides investment advice and investment management services to private investment funds. | Investment Managers | Corporate Officer/Principal Portfolio Manager-Equities |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 3 |
| Israel | 3 |
| Schweden | 3 |
| Indien | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 19 |
| Finance | 6 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 328 |
| Corporate Officer/Principal | 283 |
| Independent Dir/Board Member | 113 |
| Chief Tech/Sci/R&D Officer | 78 |
| Undergraduate Degree | 69 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Dinesh C. Paliwal | 31 |
| Frances K. Heller | 21 |
| Leif Valdemar Johansson | 21 |
| Thomas Lynch | 20 |
| Charles Sigal | 20 |
| Robert Williams | 20 |
| Gerald Storch | 19 |
| David Southwell | 19 |
| Jeremy Levin | 18 |
| Louis J. Freeh | 18 |
| Sheila Gujrathi | 18 |
| Rachel Humphrey | 17 |
| Pedro Granadillo | 16 |
| Lena Elisabeth Svanberg | 16 |
- Börse
- Insiders
- Kinnari Patel
- Unternehmensverbindungen
